Filing Details

Accession Number:
0001209191-21-054296
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-01 17:53:24
Reporting Period:
2021-08-30
Accepted Time:
2021-09-01 17:53:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674930 Fulgent Genetics Inc. FLGT Services-Medical Laboratories (8071) 812621304
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1819718 Jian Xie C/o Fulgent Genetics, Inc.
4978 Santa Anita Ave., Ste 205
Temple City CA 91780
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-30 622 $91.25 311,195 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019.
  2. The shares were sold in multiple transactions at prices ranging from $89.43 to $92.41, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.